Inter-a inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production

Soe Soe Htwe, Hidenori Wake, Keyue Liu, Kiyoshi Teshigawara, Barbara S. Stonestreet, Yow Pin Lim, Masahiro Nishibori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The plasma levels of inter-a inhibitor proteins (IAIPs) are decreased in patients with sepsis and the reduced levels correlate with increased mortality. In the present study, we examined the effects of IAIPs on human neutrophils to better understand the beneficial effects of IAIPs in the treatment of sepsis. We demonstrated that IAIPs induced a spherical shape that was smaller in size with a smooth cellular surface in a concentration-dependent manner. These changes were inhibited by a specific antibody against IAIPs. In contrast, bikunin, light chain of IAIP, had no effect on neutrophil morphology. The neutrophils treated with IAIPs could easily pass through the artificial microcapillaries and were prevented from entrapment inside the capillaries. Coincubation of human blood neutrophils with a confluent human vascular endothelial monolayer showed that adhesion of neutrophils on endothelial cells was suppressed by treatment with IAIPs. IAIPs inhibited the spontaneous release of reactive oxygen species (ROS) in a concentration-dependent fashion. ROS inhibition was associated with reductions in p47phoxphosphorylation on Ser328. These results suggest that IAIP-induced morphological changes that render neutrophils quiescent, facilitate passage through the microvasculature, and reduce adhesion to vascular endothelial cells and production of ROS. Thus, IAIP plays a key role in controlling neutrophil activation.

Original languageEnglish
Pages (from-to)1923-1934
Number of pages12
JournalBlood Advances
Volume2
Issue number15
DOIs
Publication statusPublished - Aug 14 2018

Fingerprint

Reactive Oxygen Species
Neutrophils
Proteins
Sepsis
Endothelial Cells
Neutrophil Activation
Microvessels
Blood Vessels
Light
Mortality
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inter-a inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production. / Htwe, Soe Soe; Wake, Hidenori; Liu, Keyue; Teshigawara, Kiyoshi; Stonestreet, Barbara S.; Lim, Yow Pin; Nishibori, Masahiro.

In: Blood Advances, Vol. 2, No. 15, 14.08.2018, p. 1923-1934.

Research output: Contribution to journalArticle

@article{97a225dc93584473a6685ea63b3aadea,
title = "Inter-a inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production",
abstract = "The plasma levels of inter-a inhibitor proteins (IAIPs) are decreased in patients with sepsis and the reduced levels correlate with increased mortality. In the present study, we examined the effects of IAIPs on human neutrophils to better understand the beneficial effects of IAIPs in the treatment of sepsis. We demonstrated that IAIPs induced a spherical shape that was smaller in size with a smooth cellular surface in a concentration-dependent manner. These changes were inhibited by a specific antibody against IAIPs. In contrast, bikunin, light chain of IAIP, had no effect on neutrophil morphology. The neutrophils treated with IAIPs could easily pass through the artificial microcapillaries and were prevented from entrapment inside the capillaries. Coincubation of human blood neutrophils with a confluent human vascular endothelial monolayer showed that adhesion of neutrophils on endothelial cells was suppressed by treatment with IAIPs. IAIPs inhibited the spontaneous release of reactive oxygen species (ROS) in a concentration-dependent fashion. ROS inhibition was associated with reductions in p47phoxphosphorylation on Ser328. These results suggest that IAIP-induced morphological changes that render neutrophils quiescent, facilitate passage through the microvasculature, and reduce adhesion to vascular endothelial cells and production of ROS. Thus, IAIP plays a key role in controlling neutrophil activation.",
author = "Htwe, {Soe Soe} and Hidenori Wake and Keyue Liu and Kiyoshi Teshigawara and Stonestreet, {Barbara S.} and Lim, {Yow Pin} and Masahiro Nishibori",
year = "2018",
month = "8",
day = "14",
doi = "10.1182/bloodadvances.2018018986",
language = "English",
volume = "2",
pages = "1923--1934",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "15",

}

TY - JOUR

T1 - Inter-a inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production

AU - Htwe, Soe Soe

AU - Wake, Hidenori

AU - Liu, Keyue

AU - Teshigawara, Kiyoshi

AU - Stonestreet, Barbara S.

AU - Lim, Yow Pin

AU - Nishibori, Masahiro

PY - 2018/8/14

Y1 - 2018/8/14

N2 - The plasma levels of inter-a inhibitor proteins (IAIPs) are decreased in patients with sepsis and the reduced levels correlate with increased mortality. In the present study, we examined the effects of IAIPs on human neutrophils to better understand the beneficial effects of IAIPs in the treatment of sepsis. We demonstrated that IAIPs induced a spherical shape that was smaller in size with a smooth cellular surface in a concentration-dependent manner. These changes were inhibited by a specific antibody against IAIPs. In contrast, bikunin, light chain of IAIP, had no effect on neutrophil morphology. The neutrophils treated with IAIPs could easily pass through the artificial microcapillaries and were prevented from entrapment inside the capillaries. Coincubation of human blood neutrophils with a confluent human vascular endothelial monolayer showed that adhesion of neutrophils on endothelial cells was suppressed by treatment with IAIPs. IAIPs inhibited the spontaneous release of reactive oxygen species (ROS) in a concentration-dependent fashion. ROS inhibition was associated with reductions in p47phoxphosphorylation on Ser328. These results suggest that IAIP-induced morphological changes that render neutrophils quiescent, facilitate passage through the microvasculature, and reduce adhesion to vascular endothelial cells and production of ROS. Thus, IAIP plays a key role in controlling neutrophil activation.

AB - The plasma levels of inter-a inhibitor proteins (IAIPs) are decreased in patients with sepsis and the reduced levels correlate with increased mortality. In the present study, we examined the effects of IAIPs on human neutrophils to better understand the beneficial effects of IAIPs in the treatment of sepsis. We demonstrated that IAIPs induced a spherical shape that was smaller in size with a smooth cellular surface in a concentration-dependent manner. These changes were inhibited by a specific antibody against IAIPs. In contrast, bikunin, light chain of IAIP, had no effect on neutrophil morphology. The neutrophils treated with IAIPs could easily pass through the artificial microcapillaries and were prevented from entrapment inside the capillaries. Coincubation of human blood neutrophils with a confluent human vascular endothelial monolayer showed that adhesion of neutrophils on endothelial cells was suppressed by treatment with IAIPs. IAIPs inhibited the spontaneous release of reactive oxygen species (ROS) in a concentration-dependent fashion. ROS inhibition was associated with reductions in p47phoxphosphorylation on Ser328. These results suggest that IAIP-induced morphological changes that render neutrophils quiescent, facilitate passage through the microvasculature, and reduce adhesion to vascular endothelial cells and production of ROS. Thus, IAIP plays a key role in controlling neutrophil activation.

UR - http://www.scopus.com/inward/record.url?scp=85059011099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059011099&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2018018986

DO - 10.1182/bloodadvances.2018018986

M3 - Article

C2 - 30093530

AN - SCOPUS:85059011099

VL - 2

SP - 1923

EP - 1934

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 15

ER -